Literature DB >> 18997199

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.

Antonio Nicolucci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18997199     DOI: 10.1001/jama.2008.625

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

Review 2.  Risk assessment and aspirin use in Asian and Western populations.

Authors:  Runlin Gao; Xiaoying Li
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

3.  Antiplatelet therapy for every diabetic person?

Authors:  Antonio Nicolucci; Eberhard Standl
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

4.  Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.

Authors:  Andrew D Calvin; Niti R Aggarwal; Mohammad Hassan Murad; Qian Shi; Mohamed B Elamin; Jeffrey B Geske; M Merce Fernandez-Balsells; Felipe N Albuquerque; Julianna F Lampropulos; Patricia J Erwin; Steven A Smith; Victor M Montori
Journal:  Diabetes Care       Date:  2009-09-09       Impact factor: 17.152

Review 5.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

Authors:  Giorgia De Berardis; Michele Sacco; Giovanni F M Strippoli; Fabio Pellegrini; Giusi Graziano; Gianni Tognoni; Antonio Nicolucci
Journal:  BMJ       Date:  2009-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.